Sort
48,018 grants matching “immunotherapy”
Preclinical development of CM-CX1 for the treatment of ovarian clear cell and renal cell carcinomas
$712,718Joana M Murad · Celdara Medical, Llc · R44 · FY2022 · CA
Natural killer cell engineering to target the HIV reservoir
$712,670Jerome A. Zack · University Of California Los Angeles · R01 · FY2025 · AI
Quantifying the fitness cost of HIV-1 resistance to broadly neutralizing antibodies
$712,648Rebecca Marie Lynch · George Washington University · R01 · FY2021 · AI
Regulatory Dendritic Cell Therapy in Live Donor Renal Transplant Recipients
$712,340Angus W Thomson · University Of Pittsburgh At Pittsburgh · U01 · FY2022 · AI
IMPACT OF TUBERCULOSIS OF HIV INFECTION IN UGANDA
$712,293Case Western Reserve University · R01 · FY2001 · AI
IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)AWARD OF TASK ORDER "OPTIMIZATION AND FURTHER DEVELOPMENT OF MESOTHELIN VACCINE FOR THE PREVENTION OF OVARIAN CANCER"
$712,240Nathalie Scholler · Sri International · N01 · FY2016 · CA
Targeting cancer neoantigens in patients with myeloid malignancies
$712,168Vid Leko · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Human natural killer cells: Advancing biology and clinical applications
$712,108Michael A Caligiuri · Beckman Research Institute/City Of Hope · R35 · FY2019 · CA
Evaluation of Neurobiological Mechanisms Mediating the Effect of Immune Activation on Neurocognitive Impairment and the Role of Psychosocial Factors Among Women Living with HIV
$711,991Pariya Fazeli Wheeler · University Of Alabama At Birmingham · R01 · FY2022 · MH
Structure, Function and Mechanistic Analysis of LAG3
$711,977Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
Structure, Function and Mechanistic Analysis of LAG3
$711,977Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI
Structure, Function and Mechanistic Analysis of LAG3
$711,977Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI
Structure, Function and Mechanistic Analysis of LAG3
$711,977Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AI
Decoding and reprogramming T cells through synthetic biology for cancer immunotherapy
$711,787Alexander Marson · J. David Gladstone Institutes · R01 · FY2024 · CA
Center for Interventional Oncology
$711,768Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2018 · CA
Clinical Evaluation of Chlorotoxin-redirected Chimeric Antigen Receptor (CAR) T cells for Treatment of Glioblastoma
$711,759Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Determinants of toxicity and response to immune checkpoint blockade through integrative profiling of T cell clonal dynamics and plasma cell- free DNA
$711,704Aadel Chaudhuri · Mayo Clinic Rochester · R01 · FY2024 · CA
Novel mouse models of hepatitis B virus infection and replication
$711,641Guangxiang George Luo · Wake Forest University Health Sciences · R01 · FY2025 · AI
Defining the Inflammation and Immunity Transcriptome in Severe Malarial Anemia for Immunotherapeutic Discovery
$711,525Douglas Jay Perkins · University Of New Mexico Health Scis Ctr · R01 · FY2020 · AI
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
$711,323Sharon S Evans · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Using MRI and circulating tumor DNA to improve the interpretation of response to immunotherapy and targeted therapy in CNS metastases
$711,319Elizabeth Gerstner · Massachusetts General Hospital · R01 · FY2020 · CA
Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia
$711,258Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients
$711,171Ahmed Kaseb · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Development of a platform for spatial functional genomics
$711,098Brian D Brown · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AT
Cancer Stem Cells in Cholangiocarcinoma
$711,015Changqing Xie · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA